Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Neil, Chappell"'
Autor:
Kaitlin McGrail, M.D., Susan Conway, M.D., M.P.H., M.M.Sc., John Storment, M.D., Sarah Buzhardt, M.D., Neil Chappell, M.D., M.S.C.I.
Publikováno v:
F&S Reports, Vol 1, Iss 3, Pp 202-205 (2020)
Objective: To compare the efficacy of single-dose letrozole (25 mg) with a 5-day course (5 mg/day) for ovulation induction (OI). Design: Retrospective cohort study. Setting: Hospital. Patient(s): Patients undergoing first round of OI and intrauterine
Externí odkaz:
https://doaj.org/article/d18e2c55a68a4d5998bc016eb384faac
Autor:
Pardis Hosseinzadeh, Beth Zhou, William E. Gibbons, Neil Chappell, Chellakkan S. Blesson, Amy K. Schutt
Publikováno v:
F S Sci
Background Hyperandrogenemia in an obese polycystic ovary syndrome (PCOS) mouse model results in altered glucose/insulin metabolism and mitochondrial structure and function in the oocytes, in part explaining adverse outcomes and inheritance patterns
Autor:
M. Peavey, Maya Barsky, Neil Chappell, L. Yang, Jaimin S. Shah, William Gibbons, Chellakkan S. Blesson, Haleh Sangi-Haghpeykar
Publikováno v:
F&S Reports, Vol 1, Iss 2, Pp 125-132 (2020)
F&S Reports
F&S Reports
Objective To investigate if patients with polycystic ovary syndrome (PCOS) have altered embryo morphokinetics when compared with controls. Design Retrospective cohort analysis. Setting Single academic fertility clinic in a tertiary hospital setting.
Publikováno v:
F&S Reports
F&S Reports, Vol 1, Iss 3, Pp 202-205 (2020)
F&S Reports, Vol 1, Iss 3, Pp 202-205 (2020)
Objective To compare the efficacy of single-dose letrozole (25 mg) with a 5-day course (5 mg/day) for ovulation induction (OI). Design Retrospective cohort study. Setting Hospital. Patient(s) Patients undergoing first round of OI and intrauterine ins
Publikováno v:
Endocrine Connections, Vol 9, Iss 3, Pp 261-270 (2020)
Endocrine Connections
Endocrine Connections
Polycystic ovary syndrome (PCOS) is the most common ovulatory defect in women. Although most PCOS patients are obese, a subset of PCOS women are lean but show similar risks for adverse fertility outcomes. A lean PCOS mouse model was created using pre
Publikováno v:
Fertility and sterility. 118(2)
To study the efficacy and safety of the GLP-1 analog liraglutide 3 mg (LIRA 3 mg) vs. placebo (PL) for reduction of body weight (BW) and hyperandrogenism in women with obesity and polycystic ovary syndrome (PCOS).Randomized, double-blind, placebo-con
Autor:
Liubin Yang, Mary Peavey, Khalied Kaskar, Neil Chappell, Lynn Zhu, Darius Devlin, Cecilia Valdes, Amy Schutt, Terri Woodard, Paul Zarutskie, Richard Cochran, William E. Gibbons
Publikováno v:
FS reports. 3(2)
To evaluate the feasibility of generating a center-specific embryo morphokinetic algorithm by time-lapse microscopy to predict clinical pregnancy rates.A retrospective cohort analysis.Academic fertility clinic in a tertiary hospital setting.Patients
BackgroundThe efficacy of lifestyle modifications for established obesity is limited in women with polycystic ovary syndrome (PCOS) and more aggressive interventions are needed. We assessed the efficacy and safety of the GLP-1 analogue liraglutide 3m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d4573d6257d074d1146168ff40a6a16
https://doi.org/10.21203/rs.3.rs-799341/v1
https://doi.org/10.21203/rs.3.rs-799341/v1
Publikováno v:
The Journal of clinical endocrinology and metabolism. 106(10)
Context Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors reduce weight and improve insulin sensitivity via different mechanisms. Objective The efficacy of once-weekly exenatide (EQW) and dapagliflozin (DAPA) alo
Autor:
Neil Chappell, William E. Gibbons
Publikováno v:
Clinical and Experimental Reproductive Medicine
The purpose of this paper is to assimilate all data pertaining to the use of gonadotropin-releasing hormone (GnRH) antagonists in in vitro fertilization cycles after ovulation trigger to reduce the symptoms of ovarian hyperstimulation syndrome (OHSS)